Weekly vaginal administration of tamoxifen for three months in postmenopausal women with vulvar and vaginal atrophy: a possible new treatment approach?
Journal Title: Clinical and Experimental Obstetrics & Gynecology - Year 2019, Vol 46, Issue 2
Abstract
An exploratory study was conducted recruiting four healthy postmenopausal women suffering from vulvar and vaginal atrophy (VVA). Subjects self-administered vaginal suppositories containing tamoxifen (20 mg). Subjects were instructed to insert one suppository vaginally once daily for one week and twice weekly over a period of three months. Vaginal pH and dryness scores using a visual analog scale (VAS) were recorded at enrollment and subsequent assessments were recorded using self-assessment questionnaires over a three- month period. Serum tamoxifen levels were measured after two months of suppository use. After three months, both vaginal pH and vaginal dryness symptoms showed significant improvement. Vaginal pH scores improved approximately 30% compared to baseline by completion of the study. Vaginal dryness scores improved approximately 63% compared to baseline. As expected, serum tamoxifen levels were negligible ranging from 1.0 ng/ml to 10.0 ng/ml determined after eight weeks on the treatment. The present results suggest that delivery of tamoxifen directly to the vaginal epithelium for the treatment of VVA may be a viable new treatment approach. Therefore, this route of administration may offer an important treatment modality for patients with a history of breast cancer, at risk for breast cancer, and who have hormone-receptor-positive breast cancer, including estrogen receptor-positive (ER-positive), and progesterone receptor- positive (PR-positive) in addition to node negative breast cancer.
Authors and Affiliations
J. Chollet, L. A. Meyn, F. Mermelstein
Keywords
Related Articles
- EP ID EP620253
- DOI 10.12891/ceog4948.2019
- Views 48
- Downloads 0
Influence of route of delivery on perinatal outcomes in fetuses with myelomeningocele
The optimal route of delivery of fetuses with myelomeningocele is controversial. The aim of this study is to determine whether route of delivery predisposes to perinatal complications and influences short-term outcomes i...
Cesarean scar ectopic pregnancy, a life threatening condition: a case report
A cesarean scar ectopic pregnancy (CSEP) is a rare and life-threatening condition with a prevalence of one over 3,000 pregnancies. If not promptly diagnosed, patients may undergo fatal results. There is no consensus for...
The relationship between the levels of anti-Mùˆllerian hormone, vaspin, visfatin, and the patterns of nutrition and menstruation in non-polycystic ovary syndrome and non-obese young women
Purpose of Investigation: The aim of this study was to investigate the relationship between the levels of anti-Mùˆllerian hormone (AMH), vaspin, visfatin, and the patterns of nutrition and menstruation in healthy non-pol...
Appendiceal endometriosis as a cause of ileus in pregnancy
Endometriosis is the presence of ectopic endometrial tissue outside the uterine cavity. It is a well-known cause of chronic pelvic pain and infertility in women. Endometriosis of the appendix is rare and may present with...
An observational study on diagnosis and management of adnexal masses in pregnancy
Background: Adnexal masses are seen in 1 in 80 to 1 in 8,000 pregnancies. However, with an increased use of ultrasonography in pregnancy, there is a significant rise in the incidence of adnexal masses in pregnancy. Objec...